L1CAM and Parkinson disease: In the context of disease application, Li D. et al. (2024) introduced a novel EVID-biochip (EVs identification and detection biochip) that employed a mass-based detection method alongside immunomagnetic beads to isolate and quantify L1CAM-positive EVs, specifically those linked to Parkinson’s disease.